BAP1 and cancer: Betti et al. reported that mesothelioma patients with pathogenic germline variants in BAP1, CDKN2A, or DNA repair genes had lower asbestos exposures than mesothelioma patients without germline variants in these genes or 94 other cancer-predisposing genes (P = 0.00002).